Pfizer Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Apr 2017 | 80.7% | 33.3% | 24.4% |
| Jul 2017 | 79.4% | 32.0% | 23.8% |
| Oct 2017 | 78.4% | 29.7% | 21.6% |
| Dec 2017 | 76.2% | 9.4% | 89.6% |
| Apr 2018 | 80.1% | 34.4% | 27.6% |
| Jul 2018 | 78.3% | 36.0% | 28.8% |
| Sep 2018 | 79.7% | 33.7% | 30.9% |
| Dec 2018 | 29.5% | -767.7% | -34.1% |
| Mar 2019 | 81.5% | 35.7% | 29.6% |
| Jun 2019 | 80.6% | 34.2% | 38.0% |
| Sep 2019 | 79.5% | 87.8% | 60.6% |
| Dec 2019 | 76.0% | -404.6% | -31.7% |
| Mar 2020 | 80.8% | 32.1% | 33.3% |
| Jun 2020 | 81.5% | 34.4% | 35.4% |
| Sep 2020 | 80.5% | 8.9% | 14.3% |
| Dec 2020 | 76.3% | 8.3% | 7.4% |
| Apr 2021 | 71.4% | 41.5% | 33.6% |
| Jul 2021 | 63.0% | 38.4% | 29.4% |
| Oct 2021 | 58.7% | 34.0% | 33.9% |
| Dec 2021 | 59.2% | 17.4% | 14.2% |
| Apr 2022 | 61.1% | 36.5% | 30.6% |
| Jul 2022 | 68.8% | 42.3% | 35.7% |
| Oct 2022 | 73.2% | 41.1% | 38.0% |
| Dec 2022 | 61.6% | 22.1% | 19.9% |
| Apr 2023 | 73.6% | 35.6% | 30.0% |
| Jul 2023 | 75.1% | 21.4% | 17.9% |
| Oct 2023 | 31.3% | -19.7% | -17.7% |
| Dec 2023 | 48.1% | -23.6% | -23.1% |
| Mar 2024 | 77.3% | 28.3% | 20.9% |
| Jun 2024 | 75.2% | 5.1% | 0.3% |
| Sep 2024 | 70.3% | 31.1% | 25.2% |
| Dec 2024 | 66.7% | 4.1% | 2.3% |
| Mar 2025 | 79.3% | 25.1% | 21.6% |
| Jun 2025 | 74.2% | 25.2% | 19.9% |
| Sep 2025 | 74.9% | 23.9% | 21.3% |
| Dec 2025 | 70.0% | -5.3% | -9.4% |
| Mar 2026 | 75.4% | 26.6% | 18.6% |
| Jun 2026 | 72.8% | 0.1% | -1.6% |